Trial Profile
Kronos Early Estrogen Prevention Study (KEEPS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary) ; Estradiol (Primary) ; Progesterone; Progesterone
- Indications Atherosclerosis; Menopausal syndrome
- Focus Therapeutic Use
- Acronyms KEEPS
- 17 Apr 2018 Results (n=75) of a study assessing longitudinal changes in structural brain MRI and global cognitive function 3 years after the end of mHT in KEEPS and the association of these findings with beta amyloid load on PET published in the Neurology
- 28 Aug 2017 Results (n=670) of ancillary study assessing effects of oral or transdermal estrogen therapy on sexual function in postmenopausal women published in the JAMA Internal Medicine
- 20 Jul 2017 Results related to brain volume was presented at the Alzheimer's Association International Conference 2017